Contact
Please use this form to send email to PR contact of this press release:
Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1 Study of WTX-330
TO:
Please use this form to send email to PR contact of this press release:
Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1 Study of WTX-330
TO: